Unlock AI-driven, actionable R&D insights for your next breakthrough.

Hydrogel Chemically Crosslinked: Comprehensive Analysis Of Crosslinking Strategies, Structural Properties, And Advanced Applications

APR 14, 202671 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Hydrogel chemically crosslinked represents a critical class of three-dimensional polymer networks stabilized through covalent bond formation, offering superior mechanical strength, tunable degradation kinetics, and enhanced structural integrity compared to physically crosslinked counterparts. These materials have emerged as indispensable platforms in biomedical engineering, drug delivery, tissue scaffolding, and electrochemical devices, where precise control over crosslink density, swelling behavior, and biocompatibility is paramount for achieving desired functional performance in physiologically relevant environments.
Want to know more material grades? Try Patsnap Eureka Material.

Fundamental Chemistry And Crosslinking Mechanisms Of Hydrogel Chemically Crosslinked Systems

Chemical crosslinking of hydrogels involves the formation of covalent bonds between polymer chains, creating water-insoluble three-dimensional networks capable of absorbing substantial quantities of aqueous solutions while maintaining structural integrity 15. Unlike physical hydrogels that dissolve completely in water due to absence of strong intermolecular bonds, chemically crosslinked hydrogels remain insoluble owing to permanent covalent linkages 15. The crosslinking process can be achieved through multiple strategies including chemical reagent-mediated reactions, gamma irradiation, and UV photopolymerization, with the latter two methods offering advantages of rapid gelation kinetics and elimination of potentially toxic chemical initiators 15.

The selection of crosslinking chemistry fundamentally determines the resulting hydrogel properties. Carbodiimide-mediated crosslinking, particularly using bulky organic functional groups such as optionally substituted alkyl, cycloalkyl, heterocyclic, or aryl moieties, enables controlled reaction kinetics through steric and electronic effects 711. This approach slows crosslinking rates compared to conventional 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) chemistry, allowing better process control during in situ gelation 7. Alternative strategies include thiol-ene click chemistry, which proceeds efficiently in aqueous media under mild conditions compatible with cell encapsulation, exhibiting minimal oxygen inhibition and single-step reaction profiles 16. Native chemical ligation represents another sophisticated approach, utilizing crosslinking agents with thiol groups positioned beta to primary amines, reacting with thioester-functionalized polymers at controlled pH (initially ≥4.0, then increased to 5.5-8.0) to form stable amide linkages 10.

Crosslink density critically governs hydrogel performance characteristics. For chemically crosslinked copolymer hydrogels, crosslink density typically ranges from 1×10⁻⁵ to 1×10⁻³ moles/cm³, directly influencing swelling ratios (1-35) and compressive moduli (1-35 kPa) 14. Higher crosslink densities reduce pore size and interconnectivity, limiting diffusive transport of macromolecules while enhancing mechanical strength 15. The relationship between crosslinking degree and material properties enables rational design: superabsorbent polymers (SAPs) capable of absorbing 10-1000 times their dry weight require optimized crosslink architectures balancing absorption capacity with structural stability 15.

Structural Characteristics And Material Properties Of Chemically Crosslinked Hydrogels

The molecular architecture of chemically crosslinked hydrogels determines their functional performance across diverse applications. A representative system comprises a biocompatible hydrogel core containing a covalently crosslinked polymer matrix dispersed throughout the network 2. This dual-network structure provides mechanical reinforcement while maintaining hydrophilicity. For silk fibroin-based hydrogels crosslinked with 1,4-butanediol diglycidyl ether (BDDE), the resulting materials exhibit exceptional elastic recovery, maintaining >90% volume restoration after 100 compression cycles at 20% strain 5. The crosslinking reaction targets hydroxyl- and carboxyl-containing amino acid residues, creating a stable network with controlled β-sheet content (≤40% after 30 days incubation at 37°C in PBS) and compressive modulus variation ≤100% under identical deformation conditions 5.

Thermal and chemical stability represent critical performance metrics for chemically crosslinked hydrogels. Polyvinyl alcohol (PVA)-based hydrogels crosslinked with glutaraldehyde under protic acid catalysis at ambient conditions demonstrate enhanced thermal stability at operating temperatures ≤100°C, suitable for fuel cell electrode applications 6. The water-insoluble chemical hydrogel structure resists dissolution while maintaining ionic conductivity, with electrical resistance <10,000 ohms per linear centimeter when incorporating polyvalent salts such as aluminum acetate 1. This combination of chemical stability and electrical conductivity enables transdermal drug delivery applications, where active ingredients (lidocaine hydrochloride, hydrocortisone, menthol, methyl salicylate) remain stably incorporated within the crosslinked matrix 1.

Biodegradability and biocompatibility constitute essential requirements for biomedical hydrogel applications. Silk fibroin hydrogels demonstrate tunable degradation kinetics, with BDDE crosslinking providing adjustable in vivo residence times suitable for tissue repair and filling applications 5. The materials exhibit excellent biocompatibility, supporting cell viability during encapsulation and subsequent culture 5. For polysaccharide-based systems crosslinked via native chemical ligation, the resulting hydrogels show promise for cosmetic and therapeutic applications, with degradation profiles controllable through crosslinker concentration and polymer molecular weight 10. Chitosan-lactide copolymer hydrogels offer programmable release kinetics, achieving zero-order, first-order, or second-order release profiles for incorporated bioactive agents under physiological conditions 14.

Advanced Crosslinking Strategies And Emerging Technologies For Hydrogel Chemically Crosslinked Materials

Recent innovations in crosslinking chemistry have expanded the functional capabilities of chemically crosslinked hydrogels. Bioorthogonal click chemistry utilizing complementary functional groups enables rapid gelation under biological conditions without cytotoxicity, producing hydrogels with superior mechanical strength and toughness that maintain structural integrity for months in vivo 19. These click-crosslinked systems allow cell and growth factor encapsulation without damage, addressing limitations of conventional covalent crosslinking methods that often require harsh conditions or generate toxic byproducts 19. The reaction proceeds efficiently at physiological pH and temperature, with gelation times controllable from seconds to minutes depending on reactant concentrations and catalyst selection 19.

Double-crosslinking strategies combining physical and chemical mechanisms offer synergistic property enhancements. A representative system comprises acrylic and zwitterionic monomers copolymerized in the presence of nanoparticles and chemical crosslinkers, yielding hydrogel composites with high mechanical strength, adhesion strength, and swelling resistance 4. The nanoparticle incorporation provides physical reinforcement through particle-polymer interactions, while covalent crosslinks ensure long-term stability 4. This dual-network architecture enables applications requiring both toughness and flexibility, such as load-bearing tissue scaffolds and adhesive wound dressings 4.

Thiol-disulfide exchange chemistry represents a reversible crosslinking approach enabling dynamic hydrogel properties. Branched poly(amido amine) precursors containing multiple disulfide bonds undergo pH-triggered thiol-disulfide exchange, forming crosslinked networks at elevated pH (typically 7.4-8.5) that can be subsequently stabilized by pH reduction to inhibit further exchange reactions 8. This strategy provides temporal control over gelation, allowing in situ hydrogel formation followed by network stabilization 8. The resulting materials exhibit biodegradability through disulfide bond cleavage under reducing conditions, suitable for drug delivery and tissue engineering applications requiring controlled degradation 8.

Alkoxysilyl crosslinking offers an alternative approach for biomedical hydrogels, utilizing polyvalent alkoxysilyl compounds (e.g., 3-aminopropyltriethoxysilane) to crosslink macromolecular compounds containing hydroxyl, carboxyl, amide, amino, or sulfonic acid groups 13. The reaction proceeds in aqueous media at pH 4-7 without additional catalysts, avoiding toxic catalyst residues 13. Incorporation of plasticizers such as glycerol enhances mechanical strength and chemical stability while maintaining physiological compatibility 13. The resulting hydrogels demonstrate good dimensional stability, controlled swellability, and suitability for contact with open wounds and long-term implantation 13.

Preparation Methods And Process Optimization For Hydrogel Chemically Crosslinked Systems

The synthesis of chemically crosslinked hydrogels requires careful control of reaction parameters to achieve desired material properties. For carbodiimide-crosslinked biopolymer hydrogels, the process involves dissolving the polymer (e.g., collagen, hyaluronic acid) in aqueous buffer, adding the carbodiimide crosslinker with bulky organic substituents, and allowing reaction to proceed at controlled temperature (typically 4-25°C) and pH (4.5-6.5) 711. The bulky functional groups on the crosslinker slow reaction kinetics through steric hindrance, providing extended working time for hydrogel molding or injection before gelation 7. Reaction completion typically requires 4-24 hours depending on crosslinker concentration (0.1-10 mM), polymer concentration (1-10% w/v), and temperature 711.

Photocrosslinking methods offer rapid gelation with spatial and temporal control. For thiol-ene systems, the hydrogel precursor solution containing thiol-functionalized polymers, vinyl-containing crosslinkers, and photoinitiators (typically 0.05-0.5% w/v) is exposed to UV light (320-420 nm) at intensities of 5-50 mW/cm² for durations of 30 seconds to 10 minutes 16. The reaction proceeds efficiently in aqueous media and tolerates the presence of cells, enabling cell-laden hydrogel fabrication 16. Crosslink density can be tuned by varying the stoichiometric ratio of thiol to vinyl groups (typically 0.5:1 to 2:1), light intensity, and irradiation time 16. Post-gelation washing removes unreacted monomers and photoinitiator residues, yielding biocompatible hydrogels suitable for tissue engineering applications 16.

One-step polymerization approaches simplify hydrogel production. For polyvinylpyrrolidone (PVP) hydrogels, vinyl pyrrolidone monomer is polymerized in water with a crosslinker such as 1-vinyl-3(E)-ethylidene pyrrolidone and free radical initiator under vigorous agitation sufficient to overcome polymer inertia during formation 17. This method eliminates multi-step synthesis and purification procedures, reducing production costs and time 17. The resulting lightly-crosslinked PVP hydrogels exhibit controlled swelling and mechanical properties suitable for wound dressings and drug delivery devices 17.

For silk fibroin hydrogels, the preparation involves dissolving silk fibers in lithium bromide solution (9.3 M LiBr at 60°C for 4 hours), dialyzing against water to remove salt, concentrating to desired protein content (5-20% w/v), adding BDDE crosslinker (molar ratio of BDDE to silk hydroxyl groups: 0.1-2.0), and allowing reaction at 37°C for 12-48 hours 5. The resulting hydrogels can be molded into desired shapes or processed into microspheres (50-500 μm diameter) through emulsion techniques for injectable applications 5. The crosslinking efficiency and resulting mechanical properties depend critically on silk concentration, BDDE ratio, reaction temperature, and time 5.

Performance Characterization And Structure-Property Relationships In Hydrogel Chemically Crosslinked Materials

Comprehensive characterization of chemically crosslinked hydrogels requires assessment of multiple parameters. Swelling ratio, defined as the mass of swollen hydrogel divided by dry polymer mass, typically ranges from 5 to 500 depending on crosslink density and polymer hydrophilicity 14. Measurement involves immersing dried hydrogel samples in excess buffer (pH 7.4, 37°C), periodically weighing until equilibrium swelling is achieved (typically 24-72 hours), and calculating the ratio 14. Higher crosslink densities reduce swelling by limiting network expansion, while hydrophilic polymer backbones enhance water uptake 14.

Mechanical properties are assessed through compression and tensile testing. Compressive modulus determination involves applying uniaxial compression at constant strain rate (typically 1 mm/min) to cylindrical hydrogel samples (diameter 10-20 mm, height 5-10 mm) and calculating the slope of the stress-strain curve in the linear region (typically 0-20% strain) 5. Values for biomedical hydrogels typically range from 1 kPa to 1 MPa, with higher crosslink densities yielding stiffer materials 514. Elastic recovery testing involves cyclic compression (100-1000 cycles at 10-50% strain) with measurement of permanent deformation, providing insight into network stability and fatigue resistance 5.

Degradation kinetics are evaluated through in vitro and in vivo studies. In vitro assessment involves incubating hydrogel samples in physiological buffer (PBS, pH 7.4, 37°C) with periodic measurement of mass loss, mechanical property changes, and molecular weight distribution of released polymer fragments 5. For enzymatically degradable hydrogels, specific enzymes (e.g., collagenase for collagen-based hydrogels, hyaluronidase for hyaluronic acid-based systems) are included at physiological concentrations 5. In vivo degradation studies involve subcutaneous or intramuscular implantation in animal models with explantation at defined timepoints (1 day to 6 months) for histological analysis and mechanical testing 5. Silk fibroin hydrogels crosslinked with BDDE demonstrate stable mechanical properties over 30 days in vitro, with <40% β-sheet content indicating maintained amorphous structure 5.

Biocompatibility assessment follows ISO 10993 standards, including cytotoxicity testing (extract or direct contact methods with fibroblasts or other relevant cell types, viability >70% considered non-cytotoxic), sensitization testing (guinea pig maximization test or local lymph node assay), and implantation studies (subcutaneous or intramuscular implantation in rabbits or rats with histological evaluation of inflammatory response at 1, 4, and 12 weeks) 5. Chemically crosslinked hydrogels must demonstrate minimal inflammatory response (thin fibrous capsule <100 μm thickness, absence of necrosis or chronic inflammation) to be considered biocompatible 5.

Applications Of Hydrogel Chemically Crosslinked In Biomedical Engineering And Tissue Regeneration

Chemically crosslinked hydrogels serve as versatile platforms for tissue engineering applications, where their tunable mechanical properties, biocompatibility, and degradation kinetics enable matching of native tissue characteristics. For cartilage repair, hydrogels with compressive moduli of 100-800 kPa and controlled degradation over 3-12 months support chondrocyte proliferation and extracellular matrix deposition 2. The covalently crosslinked polymer matrix provides mechanical support during tissue regeneration while gradually degrading to allow replacement by native cartilage 2. Silk fibroin hydrogels crosslinked with BDDE demonstrate particular promise for articular cartilage applications, exhibiting elastic recovery >90% after cyclic loading and providing lubrication at bone-cartilage interfaces 5. Clinical translation requires hydrogels that maintain structural integrity under physiological loads (0.5-10 MPa compressive stress during normal joint articulation) while supporting cell viability and phenotype maintenance 5.

Drug delivery applications leverage the controlled release capabilities of chemically crosslinked hydrogels. For transdermal delivery, hydrogels incorporating active pharmaceutical ingredients (APIs) such as lidocaine hydrochloride (2-5% w/w), hydrocortisone (0.5-2.5% w/w), menthol (1-5% w/w), or methyl salicylate (10-30% w/w) provide sustained release over 8-24 hours 1. The crosslinked network controls diffusion rates based on API molecular weight, hydrogel mesh size (determined by crosslink density), and API-polymer interactions 1. Electrical conductivity (resistance <10,000 ohms/cm) enables iontophoretic enhancement of transdermal transport, increasing delivery rates 10-100 fold compared to passive diffusion 1. For glucose sensing applications, hydrogels incorporating glucose oxidase (5-20% w/w) convert glucose to gluconic acid, generating potentiometric signals proportional to glucose concentration (detection range 2-20 mM, response time <5 minutes) 3. The crosslinked structure maintains enzyme activity and electrode contact for >24 hours, enabling continuous glucose monitoring 3.

Wound healing applications require hydrogels with balanced properties: sufficient mechanical strength to protect the wound bed (tensile strength >10 kPa), high water content (70-90%) to maintain moist environment, controlled swelling to absorb exudate without excessive expansion, and antimicrobial properties

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
Zhongxin Biotechnology (Zhejiang) Co. Ltd.Tissue repair and filling applications including articular cartilage regeneration, joint cavity injections for arthritis treatment, and ophthalmic applications for dry eye disease requiring injectable biomaterials with tunable biodegradability.Silk Fibroin Injectable Hydrogel MicrospheresAchieves >90% volume recovery after 100 compression cycles at 20% strain, maintains β-sheet content ≤40% and compressive modulus variation ≤100% after 30 days at 37°C in PBS, demonstrating exceptional elastic recovery and structural stability through BDDE chemical crosslinking.
SONTRA MEDICAL CORPORATIONContinuous transdermal glucose sensing for diabetes management, eliminating pain and inconvenience of frequent blood sampling through biocompatible hydrogel interface with sustained biologically active component retention.Transdermal Glucose Monitoring Hydrogel SystemIncorporates glucose oxidase (5-20% w/w) in chemically crosslinked hydrogel matrix, maintains potentiometric activity and enzyme stability for >24 hours with detection range 2-20 mM and response time <5 minutes for continuous glucose monitoring.
HENLEY INTERNATIONAL INC.Transdermal drug delivery systems requiring electrical conductivity for iontophoretic enhancement, providing sustained release over 8-24 hours for pain management, anti-inflammatory treatment, and topical therapeutic applications.Electrically Conductive Transdermal Drug Delivery HydrogelAluminum acetate crosslinking achieves electrical resistance <10,000 ohms per linear centimeter while maintaining chemical stability and enabling iontophoretic drug delivery enhancement of 10-100 fold compared to passive diffusion for lidocaine, hydrocortisone, menthol, and methyl salicylate.
President and Fellows of Harvard CollegeTissue engineering scaffolds and regenerative medicine applications requiring cell encapsulation, load-bearing tissue repair, and long-term in vivo stability under biological conditions with controlled degradation kinetics.Click-Crosslinked Bioorthogonal Hydrogel SystemBioorthogonal click chemistry enables rapid gelation under physiological conditions without cytotoxicity, producing hydrogels with superior mechanical strength and toughness that maintain structural integrity for months in vivo while allowing cell and growth factor encapsulation without damage.
OTTAWA HOSPITAL RESEARCH INSTITUTEOphthalmic devices and corneal tissue engineering applications requiring precise control over gelation kinetics, biocompatibility with ocular tissues, and adjustable crosslink density for matching native tissue mechanical properties.Carbodiimide-Crosslinked Ophthalmic HydrogelBulky organic functional group carbodiimide crosslinkers slow reaction kinetics through steric and electronic effects compared to conventional EDC chemistry, providing extended working time (4-24 hours) for controlled in situ gelation at pH 4.5-6.5 with tunable mechanical properties.
Reference
  • Crosslinked hydrogel and method for making same
    PatentInactiveUS5069908A
    View detail
  • Hydrogel with covalently crosslinked core
    PatentInactiveUS20110111033A1
    View detail
  • Biocompatible chemically crosslinked hydrogels for glucose sensing
    PatentInactiveUS7432069B2
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png